Owens W D, Waldbaum L S, Stephen C R
Anesth Analg. 1978 Mar-Apr;57(2):186-90.
Ninety-three patients 65 years of age or older were studied to determine the incidence of dysrhymia following administration of 1 of 2 cholinesterase inhibitors, neostigmine or pyridostigmine. The ECG was then continuously monitored for 90 minutes. Neostigmine was associated with a higher incidence of dysrhythmia than was pyridostigmine. Neostigmine administered to patients with pre-existing coronary artery disease and/or conduction defects and to patients with hypertension was associated with a significantly higher incidence of dysrhythmia than was pyridostigmine when administered to patients with the same conditions. The incidence of dysrhythmia in patients who received a halogenated anesthetic was 5 times greater after neostigmine than after pyridostigmine.
对93名65岁及以上的患者进行了研究,以确定给予两种胆碱酯酶抑制剂(新斯的明或吡啶斯的明)之一后心律失常的发生率。然后连续监测心电图90分钟。与吡啶斯的明相比,新斯的明与更高的心律失常发生率相关。在患有预先存在的冠状动脉疾病和/或传导缺陷的患者以及高血压患者中,给予新斯的明后的心律失常发生率显著高于给予相同病情患者吡啶斯的明后的发生率。接受卤化麻醉剂的患者在给予新斯的明后的心律失常发生率是给予吡啶斯的明后的5倍。